4.7 Article

Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas

Journal

JOURNAL OF PATHOLOGY
Volume 252, Issue 3, Pages 330-342

Publisher

WILEY
DOI: 10.1002/path.5529

Keywords

non-ampullary duodenal adenoma; small bowel adenocarcinoma; methylation; CpG island methylator phenotype; mutation

Funding

  1. JSPS KAKENHI [JP16K09304, JP19K08463, JP17K09374, JP19K08367, 16H06279]
  2. Takeda Science Foundation
  3. Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University

Ask authors/readers for more resources

The molecular and clinical characteristics of non-ampullary duodenal adenomas and intramucosal adenocarcinomas are not fully understood because they are rare. To clarify these characteristics, we performed genetic and epigenetic analysis of cancer-related genes in these lesions. One hundred and seven non-ampullary duodenal adenomas and intramucosal adenocarcinomas, including 100 small intestinal-type tumors (90 adenomas and 10 intramucosal adenocarcinomas) and 7 gastric-type tumors (2 pyloric gland adenomas and 5 intramucosal adenocarcinomas), were investigated. Using bisulfite pyrosequencing, we assessed the methylation status of CpG island methylator phenotype (CIMP) markers andMLH1. Then using next-generation sequencing, we performed targeted exome sequence analysis within 75 cancer-related genes in 102 lesions. There were significant differences in the clinicopathological and molecular variables between small intestinal- and gastric-type tumors, which suggests the presence of at least two separate carcinogenic pathways in non-ampullary duodenal adenocarcinomas. The prevalence of CIMP-positive lesions was higher in intramucosal adenocarcinomas than in adenomas. Thus, concurrent hypermethylation of multiple CpG islands is likely associated with development of non-ampullary duodenal intramucosal adenocarcinomas. Mutation analysis showed thatAPCwas the most frequently mutated gene in these lesions (56/102; 55%), followed byKRAS(13/102; 13%),LRP1B(10/102; 10%),GNAS(8/102; 8%),ERBB3(7/102; 7%), andRNF43(6/102; 6%). Additionally, the high prevalence of diffuse or focal nuclear beta-catenin accumulation (87/102; 85%) as well as mutations of WNT pathway components (60/102; 59%) indicates the importance of WNT signaling to the initiation of duodenal adenomas. The higher than previously reported frequency ofAPCgene mutations in small bowel adenocarcinomas as well as the difference in theAPCmutation distributions between small intestinal-type adenomas and intramucosal adenocarcinomas may indicate that the adenoma-carcinoma sequence has only limited involvement in duodenal carcinogenesis. (c) 2020 The Authors.The Journal of Pathologypublished by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available